While targeting the nucleus holds great promise, it also presents several challenges. The nuclear envelope is a formidable barrier that protects the genetic material inside the nucleus. Successfully delivering nanoparticles through this barrier requires overcoming several biological hurdles, such as avoiding immune system detection and ensuring biocompatibility. Additionally, the size and surface characteristics of nanoparticles must be optimized to facilitate nuclear entry without causing cellular toxicity.
